Tuberculosis remains the leading cause of death among infectious diseases, accounting for more than two million deaths annually. The incidence of the disease is increasing globally, partially because of the resurgence of drug-resistant strains of Mycobacterium tuberculosis. Calixarenes are macrocyclic oligomers, some of which are able to modify the growth of M. tuberculosis in infected cells. Most experimental work has been carried out with Macrocyclon, also known as HOC 12.5EO. In this study, we demonstrate that Macrocyclon is effective in controlling M. tuberculosis infections, and we provide evidence that its effect is partially mediated by an L-arginine-dependent mechanism of macrophage activation that involves the activity of the inducible nitric oxide synthase. We also show that Macrocyclon is effective in athymic and major histocompatibility complex class II ؊/؊ mice and synthesized a number of structurally related calixarenes expressing significant antimycobacterial activity.Mycobacterium tuberculosis infects one-third of the world's population, and it accounts for more deaths each year than any other infectious bacterium (13). The problem, associated with multiple-drug resistance (12), has prompted a great interest in understanding new alternatives in host-mediated mechanisms of disease intervention. A new therapeutic agent, with activity mediated through a host-derived effector mechanism, would be particularly attractive, since it could be less susceptible to selection for drug resistance; if the balance between the pathogenic mycobacteria and the macrophage can be manipulated in favor of the host macrophage, it may be possible to develop novel adjunctive therapies for tuberculosis control.Calixarenes have been used as building blocks for host molecules with numerous applications in supramolecular chemistry (5); some were identified as having antimycobacterial activity (3, 7). Most experimental work has been carried out with the compound Macrocyclon, also known as HOC 12.5EO, which was prepared by reacting the macrocycle HOC under basic conditions with ethylene oxide to give a heterogeneous compound with an average polyethylene glycol (PEG) chain of 12.5 U (3). The compound HOC was prepared from t-octylphenol and formaldehyde by a modified Zinke-Ziegler procedure; for many years, it was believed to be a cyclic tetrameric compound (3). Although the antibacterial mechanism of action of HOC compounds is not known, we have excluded extracellular inhibition of mycobacterial growth by Macrocyclon treatment (3,7,8). Therefore, it is believed that they work through a host-mediated mechanism (7), a view supported by reports showing activity in a wide range of in vivo models of infection in addition to tuberculosis (10). In this study, we have extended observations on the parent preparation, Macrocyclon, to show that it significantly affects mycobacterial growth in murine macrophages by a mechanism requiring inducible nitric oxide synthase (iNOS) activity. In addition, we show that Macrocyclon is effective in at...
Methodologies to access water soluble large ringed calixarenes in good yield using efficient synthetic procedures have been investigated. Symmetrical partial functionalisations at the lower rim are described using activated [n]ethylene glycol chains and the addition behaviour contrasted with that of bromoalkanenitriles which proceeds with no observed regioselectivity. Full functionalisations of the calixarenes bearing hydrophilic groups are then investigated and a two-step procedure established which appears to be generally applicable for the addition of different [n]ethylene glycol chains. Furthermore, difunctionalisation under different reaction conditions are described. Throughout, strategies for the characterisation of these high mass compounds are outlined.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.